Abound Wealth Management Acadia Pharmaceuticals Inc Transaction History
Abound Wealth Management
- $300 Billion
- Q1 2025
A detailed history of Abound Wealth Management transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Abound Wealth Management holds 7 shares of ACAD stock, worth $103. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$103% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
327Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$632 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$205 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$178 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$128 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.38B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...